Krasney Karen

Krasney Karen is listed in filings as EVP at Capricor Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 4, 2026, including sale activity. Recent filings connect the profile to Capricor Therapeutics, Inc. (CAPR). The current snapshot covers public activity from Dec 16, 2024 to May 4, 2026. Reported amounts are shown as $7.0K to $897.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.